Aeon Biopharma Inc.
13F holders, Q3 2024 (September 30)30holders +5
13new positions
7sold out
$1.05avg. 13F price*
At the end of Q3 2024, 30 institutions reported holding Aeon Biopharma Inc. in their 13F filings, up 5 from Q2 2024. 13 opened new positions and 7 sold out. The largest holders were Polar Asset Management Partners Inc. ($3.8M), Blue Owl Capital Holdings LP ($3.5M) and Vanguard Group Inc. ($789K).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $3.8M |
| Exits | 7 | $212K |
All 13F filers, Q2 2024 → Q3 2024: 4,126,161 shares bought and 295,767 shares sold, net +3,830,394 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Polar Asset Management Partners Inc. | 0.13% | Reduce -2.0% | 3,599,918 | $3.8M |
| Blue Owl Capital Holdings LP | 0.68% | New | 3,341,204 | $3.5M |
| Vanguard Group Inc. | 0.00% | No change | 751,343 | $789K |
| Formidable Asset Management, LLC | 0.07% | Add +243.0% | 389,782 | $409K |
| BlackRock, Inc. | 0.00% | — | 265,150 | $278K |
| Ikarian Capital, LLC | 0.08% | No change | 257,977 | $271K |
| Geode Capital Management, LLC | 0.00% | Add +30.1% | 243,168 | $255K |
| Bank of America Corp. | 0.00% | Add +619.6% | 166,600 | $175K |
| Two Sigma Investments, LP | 0.00% | New | 65,208 | $68K |
| Caprock Group, LLC | 0.00% | New | 62,686 | $66K |
| State Street Corp. | 0.00% | No change | 60,950 | $64K |
| UBS Group AG | 0.00% | New | 57,635 | $61K |
| Boothbay Fund Management, LLC | 0.00% | No change | 55,062 | $58K |
| Northern Trust Corp. | 0.00% | No change | 51,928 | $55K |
| LMR Partners LLP | 0.00% | Reduce -11.0% | 48,901 | $51K |
| LPL Financial LLC | 0.00% | New | 26,840 | $28K |
| HighTower Advisors, LLC | 0.00% | New | 23,776 | $25K |
| Cutter & CO Brokerage, Inc. | 0.00% | New | 14,027 | $15K |
| Lido Advisors, LLC | 0.00% | New | 12,894 | $14K |
| Corient Private Wealth LP | 0.00% | New | 12,681 | $13K |
| Dupont Capital Management Corp. | 0.00% | No change | 12,282 | $13K |
| Cetera Investment Advisers | 0.00% | New | 11,930 | $13K |
| BBR Partners, LLC | 0.00% | New | 11,586 | $12K |
| Jane Street Group, LLC | 0.00% | Reduce -54.0% | 10,710 | $11K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 7,200 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3.0% | 5,256 | $6K |
| CIBC Private Wealth Group LLC | 0.00% | New | 2,417 | $3K |
| Morgan Stanley | 0.00% | No change | 1,800 | $2K |
| GHP Investment Advisors, Inc. | 0.00% | No change | 1,095 | $1K |
| JPMorgan Chase & Co. | 0.00% | Add +87.1% | 58 | $61 |
"% of holder's portfolio" is AEON BIOPHARMA INC's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.